Clinical trial
Thalidomide-Dexamethasone for Multiple Myeloma
NCT00038090 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thalidomide-Dexamethasone for Multiple Myeloma
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2000
- Completion date
- May 31, 2005
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.